Lavipharm SA
F:BXA0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Lavipharm SA (BXA0) under the Base Case is 2.169 EUR per share. Compared with the current market price of 1.398 EUR, the stock appears Undervalued by 36% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Lavipharm Does
Lavipharm SA is a Greek pharmaceutical company that develops, makes, and sells medicines and health products. Its portfolio includes prescription drugs, over-the-counter remedies, and transdermal patches that deliver medicine through the skin. It also works with other drug companies through manufacturing, licensing, and distribution arrangements.
- Headquarters
- Greece GR
- Employees
- 285
- IPO date
- Nov 8, 1995
Balance Sheet
Continue BXA0 Research
Decided on Lavipharm? Get an email when BXA0 reaches the price you’d buy at. Free with an account.
Other Lavipharm listings
What is the Intrinsic Value of one BXA0 stock?
The intrinsic value for Lavipharm SA (BXA0) under the Base Case is 2.169 EUR.
Is BXA0 stock undervalued or overvalued?
Compared with the current market price of 1.398 EUR, the stock appears Undervalued by 36% .